2nd Quarter - Report

BOCKORNY GROUP, INC. for CVS HEALTH INC

Firm
Client
Income
$120,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues related to PBM's Issues related to drug supply chain Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals H.R.2212 - CREATES Act of 2017 Judiciary issues related to the drug supply chain

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
DANIEL FERNANDEZ —
BRAD HANTLER —
ALLEN JONES JAMERSON —
MARTI THOMAS New Deputy Assistant Secretary, Tax and Budget, Treasury; Acting and Asst Secretary, Legislative Affairs, Treasury; Assistant to COS, House Majority Leader;Floor Aide and Executive Floor Asst, House Majority Leader
NICOLE VENABLE —

Contacted: White House Office; SENATE; Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2212 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.